about
Rheumatological complications associated with the use of indinavir and other protease inhibitorsMonocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPTAntiretroviral treatments used among adults with HIV infection in Europe.A randomized trial comparing concise and standard consent forms in the START trial.Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever.Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.Factors associated with the continuum of care of HIV-infected patients in Belgium.Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.Control of viral replication after cessation of HAARTReported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialGood continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.Swab2know: An HIV-Testing Strategy Using Oral Fluid Samples and Online Communication of Test Results for Men Who Have Sex With Men in Belgium.Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial.Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individualsSexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors.Late presentation to HIV testing is overestimated when based on the consensus definition.Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.Incidence of HCV and sexually transmitted diseases among hiv positive msm in antwerp, belgium, 2001-2011.Voluntary outreach counselling and testing for HIV and STI among men who have sex with men in Antwerp.Risk factors for HCV acquisition among HIV-positive MSM in Belgium.Evaluation of the intercept oral specimen collection device with HIV assays versus paired serum/plasma specimens.Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009.Fever after a stay in the tropics: clinical spectrum and outcome in HIV-infected travelers and migrants.The use of complementary and alternative medicine by persons with HIV infection in Europe.Prevalence of chronic renal failure stage 3 or more in HIV-infected patients in Antwerp: an observational study.CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.Lipoplexes carrying mRNA encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responses.A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe.Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study).Using conventional HIV tests on oral fluid.Sexual Behavior and Sexually Transmitted Infections Among Swingers: Results From an Online Survey in Belgium.Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium - 1992 to 2012.Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection.Deteriorating renal function and clinical outcomes in HIV-positive persons.Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment.HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
P50
Q28344609-3384AD1A-9655-4851-98DD-82A048C826B0Q28730721-BBF3FAA7-B7F3-44A1-9735-E93B7FF5E99AQ31934199-E3833EAD-C75E-437F-B13D-A91B5A7987EBQ33606384-C21BBB01-FDF0-47CE-ABBB-F6778245A28CQ33629506-66635032-66BC-4342-A19D-35CEB05BC983Q34292622-AD813C79-B462-4B01-840A-754DFBA02061Q34403352-21BC1666-EAC2-45BF-A08A-097CF2FB93C4Q34475211-D108C4EB-05AB-48F1-95EB-7CEBB4F10594Q34481372-D5F1BA1E-E379-429B-9C3C-14487D24DFEDQ34615847-2CC3B276-998A-4B4F-983B-BABD2C2680E4Q35124913-340D6CE0-5F61-4209-A2E9-AD90BE53ED67Q35216275-2C255ADF-E0E7-4629-9929-68876BE37BFBQ35831085-D6FBA3D1-E126-4D7D-BB4B-03DF4EAF972AQ36274328-8ED84572-42D7-4FB2-82CA-2A5CFE403B32Q36282716-7E1A8F43-DB94-4CFA-9C71-26F5B882AD20Q36498151-C4AF4E8B-FB66-4A7A-8B65-7B703B728563Q36939372-9044A083-B09D-4473-BCA3-B4EBB77A03D6Q37279394-168443C5-5A08-4423-BBF1-3E65681C32FDQ37613840-993C6975-A55C-4D50-8E00-32C16A3ACFB6Q37844713-F323DFA6-76E8-4598-B388-4D23FED8E0DEQ37848275-F72C1DD8-7681-433C-94A7-0B2491C1485AQ38877614-8F26123C-30D4-4290-B7B7-7EAEC84C2343Q38899660-7EB7B5E5-E880-4160-B8DA-96D467D2CCD4Q38915191-82CB4592-AFE0-41F4-9181-D978725A53ACQ38916127-B6E6C37A-2D8A-4A10-8AD0-80EC18A11900Q38916141-09387C36-87DE-4F79-8F26-9BCBCE10BA40Q38950288-BFEDBE02-7813-4864-8EA8-F1F074179456Q38951176-BF7CCD13-16B0-4B63-A1DF-142752CCFDE4Q38961200-3ED7123D-0874-4FA2-8AD8-A33182F2707BQ38965589-2D3AB574-5084-4F25-B73A-8CBC6239899EQ38967636-0DCE212F-A0BF-4165-8E58-9F795DB66033Q39006632-ACE98B66-E963-4B77-B99A-FEAA79BF8508Q39006652-94A9C437-021E-4A57-B02C-61AD031EFD0CQ39010809-563E8A78-EB3C-4D73-90EC-7538232D4E50Q39024641-E2107203-8121-48F5-AD0A-D79C974AAFD2Q39128681-46E0DBE3-3498-4A5F-8E3D-400B50139240Q39179442-5A37523F-A9DB-4C03-8688-27424605500BQ39257251-6D1B8D1A-6BD1-482E-8CBF-A7430BBC28CDQ39439384-84E2B304-9406-41C8-BE73-1EC5F8A624BBQ39487637-681999CE-BDC0-4FF1-9C68-84720C0ADA3E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eric Florence
@ast
Eric Florence
@en
Eric Florence
@es
Eric Florence
@nl
type
label
Eric Florence
@ast
Eric Florence
@en
Eric Florence
@es
Eric Florence
@nl
prefLabel
Eric Florence
@ast
Eric Florence
@en
Eric Florence
@es
Eric Florence
@nl
P106
P21
P31
P3835
eric-florence
P39
P496
0000-0002-7004-9120